Generative AI is changing everything. But what’s left when the hype is gone?

No one knew how popular OpenAI’s DALL-E would be in 2022, and no one knows where its rise will leave us

It was clear that OpenAI was on to something. In late 2021, a small team of researchers was playing around with an idea at the company’s San Francisco office. They’d built a new version of OpenAI’s text-to-image model, DALL-E, an AI that converts short written descriptions into pictures: a fox painted by Van Gogh, perhaps, or a corgi made of pizza. Now they just had to figure out what to do with it.

“Almost always, we build something and then we all have to use it for a while,” Sam Altman, OpenAI’s cofounder and CEO, tells MIT Technology Review. “We try to figure out what it’s going to be, what it’s going to be used for.”

Not this time. As they tinkered with the model, everyone involved realized this was something special. “It was very clear that this was it—this was the product,” says Altman. “There was no debate. We never even had a meeting about it.” Read More

#image-recognition, #nlp, #gans

AI-generated fake faces have become a hallmark of online influence operationsAI-generated fake faces have become a hallmark of online influence operations

Fake accounts on social media are increasingly likely to sport fake faces.

Facebook parent company Meta says more than two-thirds of the influence operations it found and took down this year used profile pictures that were generated by a computer.

As the artificial intelligence behind these fakes has become more widely available and better at creating life-like faces, bad actors are adapting them for their attempts to manipulate social media networks. Read More

#fake

A brain-computer startup beat Elon Musk’s Neuralink to implanting its first device in a US patient

  • Synchron implanted its first device into a US patient on July 6 in New York.
  • The chip is designed to allow patients with severe paralysis to communicate using their thoughts.
  • Elon Musk’s Neuralink has a similar mission, but has yet to receive FDA approval.
Read More

#human